Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review.
Fiche publication
Date publication
mars 2023
Journal
Therapeutic advances in neurological disorders
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Pinto AA, De Seze J, Jacob A, Reddel S, Yudina A, Tan K
Lien Pubmed
Résumé
Intravenous immunoglobulin (IVIg) and therapeutic plasma exchange (TPE) are among the main immunotherapies for neurological disorders. Their benefit is greatest in immune-mediated conditions, but their distinct efficacy cannot be simply explained.
Mots clés
IVIg, TPE, autoantibodies, autoimmune neurological disorders, intravenous immunoglobulin, therapeutic plasma exchange, treatment efficacy
Référence
Ther Adv Neurol Disord. 2023 03 29;16:17562864231154306